These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 8267674)
1. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Yoshida N; Omoya H; Kato S; Ito T Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674 [TBL] [Abstract][Full Text] [Related]
2. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969 [TBL] [Abstract][Full Text] [Related]
3. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacological effects of the gastroprokinetic agent mosapride citrate]. Yoshida N Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676 [TBL] [Abstract][Full Text] [Related]
6. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Yamano M; Kamato T; Miyata K Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982 [TBL] [Abstract][Full Text] [Related]
7. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro. Kim HS; Choi EJ; Park H Neurogastroenterol Motil; 2008 Feb; 20(2):169-76. PubMed ID: 17931343 [TBL] [Abstract][Full Text] [Related]
8. Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying. Asakawa A; Ueno N; Katagi M; Ijuin Y; Morita Y; Mizuno S; Inui T; Sakamaki R; Shinfuku N; Uemoto M J Diabetes Complications; 2006; 20(1):56-8. PubMed ID: 16389169 [TBL] [Abstract][Full Text] [Related]
9. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats. Seto Y; Yoshida N; Kaneko H J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930 [TBL] [Abstract][Full Text] [Related]
10. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS. Sun X; Niu L; Li X; Lu X; Li F J Pharm Biomed Anal; 2009 Aug; 50(1):27-34. PubMed ID: 19362796 [TBL] [Abstract][Full Text] [Related]
11. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats. Uchida M; Yamato S; Shimizu K; Amano T; Ariga H J Pharmacol Sci; 2013; 121(4):282-7. PubMed ID: 23514789 [TBL] [Abstract][Full Text] [Related]
12. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists. Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088 [TBL] [Abstract][Full Text] [Related]
14. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Yoshikawa T; Yoshida N; Mine Y; Hosoki K Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060 [TBL] [Abstract][Full Text] [Related]
15. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs. Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810 [TBL] [Abstract][Full Text] [Related]
16. A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs. Shimatani H; Kojima Y; Kadowaki M; Nakagawa T; Fujii H; Nakajima Y; Takaki M Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G389-95. PubMed ID: 12724131 [TBL] [Abstract][Full Text] [Related]
17. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent. Kato S; Morie T; Yoshida N Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):699-702. PubMed ID: 7600620 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443 [TBL] [Abstract][Full Text] [Related]